𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glial strategy for metabolic shuttling and neuronal function

✍ Scribed by Joachim W. Deitmer

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
182 KB
Volume
22
Category
Article
ISSN
0265-9247

No coin nor oath required. For personal study only.

✦ Synopsis

Glial cells serve a variety of functions in nervous systems, some of which are activated by neurotransmitters released from neurons. Glial cells respond to these neurotransmitters via receptors, but also take up some of the transmitters to help terminate the synaptic process. Among these, glutamate uptake by glial cells is pivotal to avoid transmitter-mediated excitotoxicity. Here, a new model is proposed in which glutamate uptake via the excitatory amino acid transporter (EAAT) is functionally coupled to other glial transporters, in particular the sodium-bicarbonate cotransporter (NBC) and the monocarboxylate transporter (MCT), as well as other glial functions, such as calcium signalling, a high potassium conductance and CO(2) consumption. The central issue of this hypothesis is that the shuttling of sodium ions and acid/base equivalents, which drive the metabolite transport across the glial membrane, co-operate with each other, and hence save energy. As a result, glutamate removal from synaptic domains and lactate secretion serving the energy supply to neurons would be facilitated and could operate with greater capacity.

📜 SIMILAR VOLUMES

Roles of metabotropic glutamate receptor
Roles of metabotropic glutamate receptors in glial function and glial-neuronal communication
✍ Danny G. Winder; P. Jeffrey Conn 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 826 KB

The amino acid glutamate plays a key role in brain function. One of the major roles of glutamate is to mediate fast excitatory neurotransmission via activation of ionotropic glutamate receptors (iGluRs). More recently, however, it has become clear that glutamate also serves a regulatory function thr

hGFAP-cre transgenic mice for manipulati
hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo
✍ Lang Zhuo; Martin Theis; Ikuri Alvarez-Maya; Michael Brenner; Klaus Willecke; Al 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 921 KB

## Abstract With the goal of performing astrocyte‐specific modification of genes in the mouse, we have generated a transgenic line expressing Cre recombinase under the control of the human glial fibrillary acidic protein (hGFAP) promoter. Activity was monitored by crossing the hGFAP‐cre transgenics

Metabolism and function of gangliosides
Metabolism and function of gangliosides in developing neurons
✍ H. Dreyfus; B. Ferret; S. Harth; A. Gorio; M. Durand; L. Freysz; R. Massarelli 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 663 KB

Previous experiments have shown that the addition of a mixture of gangliosides to the growth medium induced morphological changes in primary neuronal cultures, producing especially a trophic effect and a sprouting of neurites (neuritogenesis). The study reported here examined the changes of some bio

On the reliability of 13C metabolic mode
On the reliability of 13C metabolic modeling with two-compartment neuronal-glial models
✍ Alexander A. Shestov; Julien Valette; Kâmil Uğurbil; Pierre-Gilles Henry 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 444 KB

## Abstract Metabolic modeling of ^13^C NMR spectroscopy (^13^C MRS) data using two‐compartment neuronal‐glial models enabled non‐invasive measurements of the glutamate‐glutamine cycle rate (V~NT~) in the brain in vivo. However, the reliability of such two‐compartment metabolic modeling has not bee

Alteration of glial-neuronal metabolic i
Alteration of glial-neuronal metabolic interactions in a mouse model of Alexander disease
✍ Tore Wergeland Meisingset; Øystein Risa; Michael Brenner; Albee Messing; Ursula 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 275 KB 👁 1 views

## Abstract Alexander disease is a rare and usually fatal neurological disorder characterized by the abundant presence of protein aggregates in astrocytes. Most cases result from dominant missense __de novo__ mutations in the gene encoding glial fibrillary acidic protein (GFAP), but how these mutat